Kate Zhong
Kate Zhong publishes mostly in Psychiatry and Mental health, Physiology and Economics and Econometrics, on topics such as Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #174,851 of 7,710,434 ranked researchers
- Rank in United States
- #65,346 of 1,627,098
- Works
- 51
- Citations
- 8.3k
- Citations per work
- 162.0
What does Kate Zhong research?
Kate Zhong's work is mostly in Medicine (41%), Biochemistry, Genetics and Molecular Biology (10%), Economics, Econometrics and Finance (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2140.6%
- Medicine2140.6%
- Everything else1632.1%
- Social Sciences916.8%
- Life Sciences510.5%
- 1Psychiatry and Mental health19% of their works
- 2Physiology15% of their works
- 3Economics and Econometrics10% of their works
- 4Molecular Biology10% of their works
- 5Pharmacology7% of their works
- 6Clinical Psychology6% of their works
Research topics
- Alzheimer's disease research and treatments
- Dementia and Cognitive Impairment Research
- Health Systems, Economic Evaluations, Quality of Life
- Cholinesterase and Neurodegenerative Diseases
- Schizophrenia research and treatment
- Healthcare Decision-Making and Restraints
- Phosphodiesterase function and regulation
- Neurological Disorders and Treatments
Which keywords describe Kate Zhong's research?
The keywords of their largest research topics: Alzheimer's Disease, Oxidative Stress, Amyloid Hypothesis, Tau Pathology, Dementia, Mild Cognitive Impairment, Cost-effectiveness Analysis and Quality of Life.
- cAMP Signaling
- Citicoline
- Psychiatric Treatment
- Informed Consent
- Cholinesterase Inhibitors
- Quality of Life
- Mild Cognitive Impairment
- Tau Pathology
- Oxidative Stress
- Alzheimer's Disease
- Amyloid Hypothesis
- Dementia
- Cost-effectiveness Analysis
- Acetylcholinesterase
- Antipsychotic Drugs
- Neurocognitive Deficits
- Cerebrolysin
- Cyclic Nucleotide Phosphodiesterases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Alzheimer's Disease323 topics
- Oxidative Stress262 topics
- Amyloid Hypothesis201 topic
- Tau Pathology201 topic
- Dementia181 topic
- Mild Cognitive Impairment181 topic
- Cost-effectiveness Analysis101 topic
- Quality of Life101 topic
- Acetylcholinesterase81 topic
- Cholinesterase Inhibitors81 topic
- Antipsychotic Drugs71 topic
- Informed Consent71 topic
- Neurocognitive Deficits71 topic
- Psychiatric Treatment71 topic
- Cerebrolysin61 topic
- Citicoline61 topic
- Cyclic Nucleotide Phosphodiesterases61 topic
- cAMP Signaling61 topic
Where does Kate Zhong work?
Kate Zhong's main affiliation in the publication record is Lou Ruvo Brain Institute, United States.
How many publications and citations does Kate Zhong have?
OpenAlex counts 51 works and 8,263 citations for Kate Zhong, an h-index of 26, ranking #174,851 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kate Zhong. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.